FAQ

1. What makes Injeq IQ-Tip® spinal needle unique?

The use of Injeq IQ-Tip® System is associated with a lower incidence of the most common complications associated with lumbar punctures, such as post-dural puncture headache and traumatic lumbar puncture. Injeq IQ-Tip® spinal needle employs real-time bioimpedance spectroscopy for tissue detection and can tell the user when the needle tip reaches cerebrospinal fluid (CSF) with an audio-visual alarm. The CSF alarm may help the physician avoid unnecessary needle movements around the blood vessels and nerve roots in the spinal cavity and so avoid possible complications.

Read more

2. Where and how can I buy the Injeq IQ-Tip® spinal needle?

Injeq IQ-Tip® spinal needle received CE certification in December 2021 and is now free for sales in European Union area. Please check from our contact page your local distributor. In case you cannot find a suitable distributor please contact info@injeq.com and we will guide you further .

3. Can Injeq IQ-Tip® system be used for other than neonatal and pediatric lumbar punctures?

Yes, Injeq IQ-Tip® system may be used to any patient to whom a lumbar puncture with a 22G spinal needle is medically indicated. Injeq IQ-Tip® system has been found feasible and safe in clinical studies in adult, pediatric and neonatal patient populations.

4. What is the smallest size of the needle for neonatal lumbar punctures?

All Injeq IQ-Tip® spinal needles are size 22G (outer diameter 0,7mm) but the shortest needle, convenient for neonates, is 41 mm long.

5. What are the main benefits Injeq IQ-Tip® system can offer to my clinical work?

Injeq IQ-Tip system is easy-to-use and it alerts you with an audiovisual alarm when the tip of the spinal needle reaches the cerebrospinal fluid (CSF) in the subarachnoid space. You can then stop advancing the needle and remove the stylet for checking the CSF flow.  The use of IQ-Tip system is associated with a high first puncture success rate as well as a low incidence of traumatic punctures and post-dural puncture headache (PDPH).

6. Is it possible to do scientific collaboration with Injeq?

Yes, Injeq is interested in conducting both methodological and clinical studies with its products. Injeq has strong and long expertise on its topic and has tight links to Tampere University. Injeq has also conducted several clinical studies with several Finnish university hospitals. Please contact CSO Harri Sievänen, ScD (Biomed. Eng.), harri.sievanen@injeq.com for further information.

7. Does Injeq IQ-Tip® system collect sensitive patient and health information?

No, data safety and protection are not an issue with Injeq IQ-Tip® system. For research purposes, the system may be activated to collect only bioimpedance information and it is impossible to identify the patient from the collected data.